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Ethyl alcohol (ethanol) is produced by
the process of fermentation whereby plant
sugars are converted to ethanol by yeast.
Products of fermentation include mead
from honey, wine from grapes, sake from
rice, and beer from grains. Fermented
products can also be distilled, for exam-
ple when whisky is distilled from grains
(Herbst and Herbst, 2003). The history of
voluntary ethanol use by humans dates as
far back as 8000 years ago for wine and
possibly earlier for beer, as barley may have
been the oldest cultivated grain (Pendell,
2010). It is also documented that ethanol
was an extremely important staple to
ancient civilizations such as the Egyptians
and the Maya (Johnson, 1994), as well as
more modern societies such as the origi-
nal American colonies (Pendell, 2010). It
seems that modern society’s interest in
alcohol has certainly not waned, and from
the standpoint of neuropharmacology, has
probably increased.
During the past several decades, there
has been a concerted effort to determine
the neuropharmacological mechanism of
action(s) of ethanol. Ethanol has been
reported to produce its effects via modu-
lation of neural cell membrane fluidity as
well as modulation of several neurotrans-
mitter systems, including γ-amino butyric
acid (GABA), glutamate, dopamine, and
opioid systems (for reviews, see Koob
et al., 1998; Kumar et al., 2009). GABA is
an inhibitory amino acid neurotransmit-
ter that is ubiquitously distributed in the
mammalian brain, and ethanol’s effects on
the GABA system are thought to be medi-
ated primarily by activating the GABAA
receptor, a 5-subunit receptor that gates
Cl− ions (for a review, see Kumar et al.,
2009). Thus, GABA receptor activation
produces CNS inhibition via Cl− influx.
It has also been reported that specific
GABAA receptor subunits mediate specific
effects. For example, the α1 subunit is
associated with sedation, whereas the α2
and α3 subunits are associated with anti-
anxiety effects (Licata and Rowlett, 2008;
Ator et al., 2010). Many types of sedative-
hypnotic compounds (drugs producing
dose-dependent sedation and ultimately
sleep), including the benzodiazepines, bar-
biturates, and ethanol, bind to and activate
the GABAA receptor, and it is reasonable
to assume that the sedative effects of these
agents are mediated, at least in part, by the
α1 subunit.
It is known that neurotransmitters,
including GABA, bind to their receptors
as “first messengers,” and initiate a com-
plex cascade of intra-cellular events. In the
case of GABA, part of this cellular cascade
includes modulation of the “second mes-
senger” systems Ca++ and cAMP that ulti-
mately modulate two protein kinases, PKC
and PKA, resulting in myriad effects in the
cell, including changes to gene expression
(Moss et al., 1992; Diamond and Gordon,
1997; Brandon et al., 2000 for a review, see
Kumar et al., 2009).
Leslie Morrow and colleagues have
been exploring the complex cascade of
downstream cellular events mediated
by ethanol-induced GABAA receptor
activation. In their recent Frontiers in
Neuroscience report (Kumar et al., 2012),
this research team determined the effects
of acute ethanol exposure on PKA-
mediated GABAA receptor expression.
Although chronic ethanol exposure has
been reported to produce down-regulation
and/or desensitization of GABAA recep-
tors, Morrow and colleagues reported
an interesting finding of acute ethanol
exposure. Specifically, acute intracere-
broventricular administration of ethanol
produced dose-dependent increases in
expression of PKA and GABAA receptor
α1 subunits. In addition, antagonism stud-
ies revealed that blockade of PKA blocked
the ethanol-induced increases in GABAA
receptor α1 subunit expression, provid-
ing further evidence for a PKA-GABAA
receptor network communication. An
additional manipulation showed that
enhancing PKA activity actually enhanced
ethanol-induced loss of righting reflex.
Together with earlier reports from this
research group, these data indicate that
PKA (Kumar et al., 2012) and PKC (Kumar
et al., 2006) may have antagonistic effects
on GABAA receptor α1 subunit expres-
sion, thus delineating specific potential
pathway(s) for mediation of ethanol
effects on cell function and overt organis-
mal behavior. This group’s current report
represents a comprehensive analysis of the
specific effects of ethanol on kinase activ-
ity and receptor subunit expression levels,
and adds another layer of knowledge
about the neuropharmacological mech-
anisms of ethanol. It is quite possible that
further elucidation of the complex molec-
ular “systems level” analysis of ethanol’s
actions in nerve cells may yield important
“systems level” approaches and advances
for the treatment of alcohol abuse and
dependence.
Frontiers in Neuroscience www.frontiersin.org July 2013 | Volume 7 | Article 122 | 1
Stevenson and Fox The neuropharmacology of the age-old sedative/hypnotic, ethanol
ACKNOWLEDGMENTS
Meredith A. Fox was supported by the
National Institute of Mental Health
(NIMH) Intramural Research Program.
REFERENCES
Ator, N. A., Atack, J. R., Hargreaves, R. J., Burns, D.,
and Dawson, G. R. (2010). Reducing abuse liabil-
ity of GABAA/Benzodiazepine ligands via selec-
tive partial agonist efficacy at α1 and α2/3 sub-
types. J. Pharmacol. Exp. Ther. 332, 4–16. doi:
10.1124/jpet.109.158303
Brandon, N. J., Delmas, P., Kittler, J. T., McDonald,
B. J., Sieghart, W., Brown, D. A., et al. (2000).
GABAA receptor phosphorylation and functional
modulation incortical neurons by a protein
kinase C-dependent pathway. J. Biol. Chem. 275,
38856–38862.
Diamond, I., and Gordon, A. S. (1997). Cellular
and molecular neuroscience of alcoholism. Physiol.
Rev. 77, 1–20.
Herbst, R., and Herbst, S. T. (2003). The Wine Lover’s
Companion. 2nd edn. Hauppauge, NY: Barron’s
Educational Series.
Johnson, H. (1994). The World Atlas of Wine. 4th edn.
New York, NY: Simon and Schuster.
Koob, G. F., Roberts, A. J., Schulteis, G., Parsons,
L. H., Heyser, C. J., Hyytiä, P., et al. (1998).
Neurocircuitry targets in ethanol reward and
dependence. Alcohol. Clin. Exp. Res. 22, 3–9. doi:
10.1111/j.1530-0277.1998.tb03611.x
Kumar, S., Lane, B. M., and Morrow, A. L. (2006).
Differential effects of systemic ethanol adminis-
tration on protein kinase cepsilon, gamma, and
beta isoform expression, membrane translocation,
and target phosphorylation: reversal by chronic
ethanol exposure. J. Pharmacol. Exp. Ther. 319,
1366–1375. doi: 10.1124/jpet.106.110890.
Kumar, S., Porcu, P., Werner, D. F., Matthews, D.
B., Diaz-Granados, J. L., Helfand, R. S., et al.
(2009). The role of GABA(A) receptors in the
acute and chronic effects of ethanol: a decade of
progress. Psychopharmacology 205, 529–564. doi:
10.1007/s00213-009-1562-z.
Kumar, S., Ren, Q., Beckley, J. H., O’Buckley, T.
K., Gigante, E. D., Santerre, J. L., et al. (2012).
Ethanol activation of protein kinase A regu-
lates GABA(A) receptor subunit expression in
the cerebral cortex and contributes to ethanol-
induced hypnosis. Front. Neurosci. 6:44. doi:
10.3389/fnins.2012.00044s
Licata, S. C., and Rowlett, J. K. (2008). Abuse
and dependence liability of benzodiazepine-type
drugs: GABAA receptor modulation and beyond.
Pharmacol. Biochem. Behav. 90, 74–89. doi:
10.1016/j.pbb.2008.01.001
Moss, S. J., Doherty, C. A., and Huganir, R. L.
(1992). Identification of the cAMP-dependent pro-
tein kinase and protein kinase C phosphorylation
sites within the major intracellular domains of the
beta1, gamma 2S, and gamma2L sub-units of the
gamma-aminobutyric acid type A receptor. J. Biol.
Chem. 267, 14470–14476.
Pendell, D. (2010). Pharmakopoeia: Power Plants,
Poisons and Herbcraft. (Updated edn.). Berkeley,
CA: North Atlantic Books.
Received: 18 April 2013; accepted: 25 June 2013;
published online: 15 July 2013.
Citation: Stevenson GW and Fox MA (2013) The
neuropharmacology of the age-old sedative/hypnotic,
ethanol. Front. Neurosci. 7:122. doi: 10.3389/fnins.
2013.00122
Copyright © 2013 Stevenson and Fox. This is an open-
access article distributed under the terms of the Creative
Commons Attribution License, which permits use, dis-
tribution and reproduction in other forums, provided
the original authors and source are credited and sub-
ject to any copyright notices concerning any third-party
graphics etc.
Frontiers in Neuroscience www.frontiersin.org July 2013 | Volume 7 | Article 122 | 2
